[{"id":"be4d24f9-af35-478a-8f00-f72eff41ba99","acronym":"","url":"https://clinicaltrials.gov/study/NCT04162119","created_at":"2021-01-18T20:17:53.745Z","updated_at":"2024-07-02T16:36:53.560Z","phase":"Phase 2","brief_title":"Safety and Efficiency Study of BCMA-PD1-CART Cells in Relapsed/Refractory Multiple Myeloma","source_id_and_acronym":"NCT04162119","lead_sponsor":"Chinese PLA General Hospital","biomarkers":" PD-1","pipe":"","alterations":" ","tags":["PD-1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • BCMA-PD1-CART Cells"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 07/07/2019","start_date":" 07/07/2019","primary_txt":" Primary completion: 10/10/2021","primary_completion_date":" 10/10/2021","study_txt":" Completion: 10/10/2022","study_completion_date":" 10/10/2022","last_update_posted":"2019-11-18"}]